Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec 27;73(12):2013-8.
doi: 10.1021/np1004455. Epub 2010 Nov 10.

Clerodane diterpenes from Casearia arguta that act as synergistic TRAIL sensitizers

Affiliations

Clerodane diterpenes from Casearia arguta that act as synergistic TRAIL sensitizers

Emily L Whitson et al. J Nat Prod. .

Abstract

Casearia arguta was investigated as part of the ongoing search for synergistic TRAIL (tumor necrosis factor-α-related apoptosis-inducing ligand) sensitizers. As a result of this study, argutins A-H, eight new highly oxygenated clerodane diterpenes, were isolated from the plant Casearia arguta collected in Guatemala. The modified Mosher ester method was utilized to establish the absolute configuration of argutins A and F. Each of the argutins showed varying levels of synergy with TRAIL. Argutin B showed the highest TRAIL sensitization; the synergistic effect of argutin B and TRAIL together was 3-fold greater than argutin B alone.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Key ROE correlations supporting the configuration of argutin A (1).
Figure 2
Figure 2
ΔδSR values (ΔδSR = δS – δR) for the MTPA esters 1S and 1R.
Figure 3
Figure 3
ΔδSR values (ΔδSR = δS – δR) for the MTPA esters 9S and 9R.

Similar articles

Cited by

References

    1. Mahalingam D, Szegezdi E, Keane M, Jong S, Samali A. Cancer Treat. Rev. 2009;35:280–288. - PubMed
    1. Booth NL, Sayers TJ, Brooks AD, Thomas CL, Jacobsen K, Goncharova EI, McMahon JB, Henrich CJ. Cancer Immunol. Immunother. 2009;58:1229–1244. - PMC - PubMed
    1. Zhang L, Fang B. Cancer Gene Ther. 2005;12:228–237. - PubMed
    1. Van Geelen CM, de Vries EG, de Jong S. Drug Resist. Updat. 2004;7:345–358. - PubMed
    1. O'Kane HF, Watson CJ, Johnston SR, Petak I, Watson RW, Williamson KE. J. Urol. 2006;175:432–438. - PubMed

Publication types

MeSH terms